Three of the six (50%) ccRCC control cases showed expected VHL mutations; two (33%) harbored pathogenic mutations in the p53 or the CKIT genes; and one (16%) was wild type. The gene discussed is TP53; the disease is nonpapillary renal cell carcinoma.